2016Chinese Journal of NeuromedicineRequires access

Recent advance in relation of neuromyelitis optica with anti-aquaporin-4 antibody

Fang Mi

Open publisher page 0 citations

Abstract

Neuromyelitis optica(NMO)is an inflammatory demyelinating disorder of the central nervous system(CNS)that predominantly affects the optic nerve and spinal cord. It has long been controversial about the concept whether NMO is an independent disease, or a subtype of multiple sclerosis(MS). In 2004, anti-AQP4 antibody was found in the sera of NMO patients, which gradually indicates that NMO is an independent disease different from MS. The discovery of anti-AQP4 antibody will not only contribute to the clinical diagnosis, early treatment and prognosis of NMO, but also make us do further research on NMO. We mainly reviewed the role of anti-AQP4 antibody in pathogenesis of NMO, detection methods and clinical significance of NMO. Key words: Neuromyelitis optica; Anti-aquaporin-4 antibody; Demyelinating disease

About this research paper

What this paper is about

Neuromyelitis optica(NMO)is an inflammatory demyelinating disorder of the central nervous system(CNS)that predominantly affects the optic nerve and spinal cord. It has long been controversial about the concept whether NMO is an independent disease, or a subtype of multiple sclerosis(MS). In 2004, anti-AQP4 antibody was found in the sera of NMO patients, which gradually indicates that NMO is an independent disease different from MS. The discovery of anti-AQP4 antibody will not only contribute to the clinical diagnosis, early treatment and prognosis of NMO, but also make us do further research on NMO. We mainly reviewed the role of anti-AQP4 antibody in pathogenesis of NMO, detection methods and clinical significance of NMO. Key words: Neuromyelitis optica; Anti-aquaporin-4 antibody; Demyelinating disease

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Neuromyelitis optica(NMO)is an inflammatory demyelinating disorder of the central nervous system(CNS)that predominantly affects the optic nerve and spinal cord. It has long been controversial about the concept whether NMO is an independent disease, or a subtype of multiple sclerosis(MS). In 2004, anti-AQP4 antibody was found in the sera of NMO patients, which gradually indicates that NMO is an independent disease different from MS. The discovery of anti-AQP4 antibody will not only contribute to the clinical diagnosis, early treatment and prognosis of NMO, but also make us do further research on NMO. We mainly reviewed the role of anti-AQP4 antibody in pathogenesis of NMO, detection methods and clinical significance of NMO. Key words: Neuromyelitis optica; Anti-aquaporin-4 antibody; Demyelinating disease

Key concepts: Neuromyelitis optica, Multiple sclerosis, Medicine, Demyelinating disease, Aquaporin 4, Antibody, Spectrum disorder, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Recent advance in relation of neuromyelitis optica with anti-aquaporin-4 antibody — Research Paper | ScholarLens